Heart Amyloidosis, Meneghin (Fipc): "Customized Medicine Requires Cultural Change"
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.6 Articles
6 Articles
(Adnkronos) - Scientific and biotechnological innovation, from pharmacology to personalized medicine, can transform people's lives only if accompanied by a cultural change. "Cristina Meneghin, director of scientific communication, Italian Foundation for the heart, intervening in Rome at the event "The age" is not a diagnosis. Personalized medicine, between genetic testing and prescriptive appropriateness: the... Continue readingThe articleAmyloi…
Rec News | Lontani dal mainstream
notizie.it(Adnkronos) - Scientific and biotechnological innovation, from pharmacology to personalized medicine, can transform people's lives only if accompanied by a cultural change. "Cristina Meneghin, director of scientific communication, Italian Foundation for the heart, intervening in Rome at the event "L'età" is not a diagnosis. Personalized medicine, between genetic testing and prescriptive appropriateness: the [...] L'articolo Amyloidosis cardiac, …
Giornale Radio
"The scientific and biotechnological innovation, from pharmacology to personalized medicine, can transform people's lives only if accompanied by a cultural change." Cristina Meneghin, director of scientific communication, Fondazione Italiana per il cuore, said, intervening in Rome at the event 'The age is not a diagnosis. Personalized medicine, between genetic testing and prescriptive appropriateness: the case of cardiac amyloidosis' promoted by…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
